Generic Allegra To Remain On The Market

Law360, New York (November 8, 2006, 12:00 AM EST) -- A U.S. appeals court has affirmed without comment a lower court ruling that will allow Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. to continue selling generic versions of allergy drug Allegra.

The ruling, handed down Wednesday by the U.S. Court of Appeals for the Federal Circuit, denied a preliminary injunction sought by French drug maker Sanofi-Aventis to prevent rivals from making generic versions of the allergy drug while it sues them for patent infringement.

Sanofi-Aventis, along with its licensing partner Albany Molecular Research Inc. (AMRI),...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.